Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$4.56B |
| 2 |
Broadcom
AVGO
|
+$441M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$281M |
| 4 |
NVIDIA
NVDA
|
+$278M |
| 5 |
Microsoft
MSFT
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$2.05B |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$1.6B |
| 3 |
Lennox International
LII
|
+$284M |
| 4 |
Itaú Unibanco
ITUB
|
+$247M |
| 5 |
Intuit
INTU
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Financials | 19.13% |
| 3 | Healthcare | 9.52% |
| 4 | Industrials | 9.41% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Independence Realty Trust
IRT
$4B
| $20M | 0.01% |
1,145,635
-56,552
| -5% | -$937K |
|
327
BioCryst Pharmaceuticals
BCRX
$2.38B
| $19.2M | 0.01% |
2,467,567
-165,129
| -6% | -$1.19M |
|
328
Revolution Medicines
RVMD
$42.4B
| $19.2M | 0.01% |
241,057
+233,752
| +3,200% | +$15.3M |
|
329
Berkshire Hathaway Class B
BRK.B
$1.13T
| $19.2M | 0.01% |
38,195
+2,727
| +8% | +$1.36M |
|
330
Oceaneering
OII
$4.9B
| $19.1M | 0.01% |
793,098
+153,214
| +24% | +$3.7M |
|
331
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $18.6M | 0.01% |
794,901
+29,695
| +4% | +$699K |
|
332
Fluor
FLR
$6.81B
| $18.4M | 0.01% |
463,162
+25,998
| +6% | +$1.15M |
|
333
TechnipFMC
FTI
$27.3B
| $18.2M | 0.01% |
408,437
+27,111
| +7% | +$1.14M |
|
334
Box
BOX
$4.41B
| $18.2M | 0.01% |
607,138
-56,143
| -8% | -$1.76M |
|
335
Merit Medical Systems
MMSI
$5.24B
| $18.1M | 0.01% |
205,003
-16,606
| -7% | -$1.41M |
|
336
Kaiser Aluminum
KALU
$2.8B
| $18M | 0.01% |
157,078
+19,291
| +14% | +$1.84M |
|
337
Freshpet
FRPT
$3.21B
| $18M | 0.01% |
295,712
+7,550
| +3% | +$428K |
|
338
Steel Dynamics
STLD
$37.5B
| $17.8M | 0.01% |
105,083
+70,205
| +201% | +$11.1M |
|
339
BridgeBio Pharma
BBIO
$16.2B
| $17.8M | 0.01% |
+232,401
| New | +$15.3M |
|
340
Acadia Pharmaceuticals
ACAD
$4.9B
| $17.8M | 0.01% |
665,087
+26,595
| +4% | +$636K |
|
341
SM Energy
SM
$6.88B
| $17.7M | 0.01% |
944,067
+47,735
| +5% | +$967K |
|
342
First Financial Bancorp
FFBC
$3.55B
| $17.5M | 0.01% |
699,057
-23,343
| -3% | -$583K |
|
343
Materion
MTRN
$5.8B
| $17.4M | 0.01% |
140,265
-8,432
| -6% | -$1.04M |
|
344
ITT
ITT
$19.2B
| $17.4M | 0.01% |
100,449
+37
| +0% | +$6.63K |
|
345
Ovintiv
OVV
$16.6B
| $17.3M | 0.01% |
442,296
-21,145
| -5% | -$820K |
|
346
AAR Corp
AIR
$5.89B
| $17.1M | 0.01% |
207,003
+3
| +0% | +$248 |
|
347
Prestige Consumer Healthcare
PBH
$2.58B
| $16.9M | 0.01% |
273,885
-19,824
| -7% | -$1.21M |
|
348
Commerce Bancshares
CBSH
$8.51B
| $16.9M | 0.01% |
322,335
+57,941
| +22% | +$3.03M |
|
349
Cal-Maine
CALM
$3.98B
| $16.8M | 0.01% |
211,341
-9,440
| -4% | -$829K |
|
350
Church & Dwight Co
CHD
$24.5B
| $16.6M | 0.01% |
198,441
+104,092
| +110% | +$8.89M |
|
Similar funds
Ken Fisher's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Fisher held 1,126 positions worth $293B, up 6% from $276B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Fisher's Q4 2025 filing shows 112 new, 480 increased, 403 reduced and 109 closed positions. Its largest new stake was Belden: 369,776 shares worth $43.1M. The largest sale was iShares MBS ETF, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2025 buy was Belden: 369,776 shares worth $43.1M.
- Ken Fisher added most to iShares 7-10 Year Treasury Bond ETF in Q4 2025, an estimated $4.56B increase.
- Ken Fisher's biggest Q4 2025 reduction was iShares MBS ETF, cutting an estimated $2.05B.
- Ken Fisher fully exited Infosys in Q4 2025, selling an estimated $146M.
- Ken Fisher's ten largest holdings make up 34% of its $293B portfolio in Q4 2025.
- Ken Fisher opened 112 new positions and closed 109 in Q4 2025.
- Ken Fisher's portfolio value rose 6% quarter-over-quarter to $293B.
Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.